Neoplastic diseases are the second cause of death. Each year about 90 thousand people die because of cancer. It is estimated that this number will keep growing, becoming in the near future, the first cause of death before 65 years of age for both women and men. Tumors are a serious health and social problem of the 21st century.
Pancreatic cysts are very frequent radiological findings. It is said that such changes may be found by MR examination in every fifth person. The most frequent type of cysts are postinflammatory ones. Their recognition is not difficult because patients report experienced acute or chronic pancreatitis. Diagnostic problem emerges when it is known that a cyst has no inflammatory basis. Serous cystadenomas, intraductal papillary mucinous neoplasms and cystic tumours may appear among cystic changes. However, only serous cystadenomas cause no immediate risk of malignant transformation. It is connected with the need of exact analysis of such changes regarding potential development of malignant tumour. Read full text »
The latest research compared survival of patients with diagnosed terminal brain tumour who were treated with standard methods and with the use of experimental vaccine developed individually for every patient. The results have shown that the use of the vaccine brings very beneficial effects and prolong life of the patients.
Radiosurgical Gamma Knife is a device used to treat benign and malignant brain tumors as well as some of the other diseases of the nervous system. Gamma Knife (also known as the Leksell Gamma Knife-from the name of one of the originators) was invented in Sweden in the 60s. The principle of the intervention is to deliver a high dose of cobalt radiation concentrated in a small area. Read full text »
German scientists came up with the discovery of a new biomarker which could be controlled to assess a response to chemotherapy of colorectal cancer. Indication of methylation of transcription factor AP-2 epsilon (TFAP2E) gens can be useful medical examination, helping to determine a chemotherapy resistance. (1,2) Read full text »